Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Dixon

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Pharmacology|June 5, 1999
Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cellsS C Dixon, E A Kruger, K S Bauer, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 30, 1999
The androgen receptor: genetic considerations in the development and treatment of prostate cancerK J Cude, S C Dixon, Y Guo, et al.
The Biochemical Journal|February 1, 1985
The use of monoclonal antibodies to study the proteins specified by the transforming region of human adenovirusesM E Blair Zajdel, M D Barker, S C Dixon, et al.
Plant Physiology|July 1, 1982
Cytokinin structure-activity relationships and the metabolism of N-(delta-isopentenyl)adenosine-8-C in phaseolus callus tissuesM C Mok, D W Mok, S C Dixon, et al.
Plant Physiology|August 1, 1989
Zeatin Glycosylation Enzymes in Phaseolus: Isolation of O-Glucosyltransferase from P. lunatus and Comparison to O-Xylosyltransferase from P. vulgarisS C Dixon, R C Martin, M C Mok, et al.
British Journal of Cancer|April 3, 1999
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitorJ Horti, S C Dixon, C J Logothetis, et al.
The Annals of Pharmacotherapy|January 1, 1997
Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic targetS C Dixon, B J Soriano, R M Lush, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathwayK S Bauer, K J Cude, S C Dixon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factorE J Small, D M Reese, B Um, et al.
Cancer Letters|February 26, 1997
In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3S C Dixon, A Zalles, C Giordano, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|June 5, 1999
Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cellsS C Dixon, E A Kruger, K S Bauer, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 30, 1999
The androgen receptor: genetic considerations in the development and treatment of prostate cancerK J Cude, S C Dixon, Y Guo, et al.
The Biochemical Journal|February 1, 1985
The use of monoclonal antibodies to study the proteins specified by the transforming region of human adenovirusesM E Blair Zajdel, M D Barker, S C Dixon, et al.
Plant Physiology|July 1, 1982
Cytokinin structure-activity relationships and the metabolism of N-(delta-isopentenyl)adenosine-8-C in phaseolus callus tissuesM C Mok, D W Mok, S C Dixon, et al.
Plant Physiology|August 1, 1989
Zeatin Glycosylation Enzymes in Phaseolus: Isolation of O-Glucosyltransferase from P. lunatus and Comparison to O-Xylosyltransferase from P. vulgarisS C Dixon, R C Martin, M C Mok, et al.
British Journal of Cancer|April 3, 1999
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitorJ Horti, S C Dixon, C J Logothetis, et al.
The Annals of Pharmacotherapy|January 1, 1997
Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic targetS C Dixon, B J Soriano, R M Lush, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathwayK S Bauer, K J Cude, S C Dixon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factorE J Small, D M Reese, B Um, et al.
Cancer Letters|February 26, 1997
In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3S C Dixon, A Zalles, C Giordano, et al.
Pageof 3